GAM
Groupama Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150M | Buy |
1,409,776
+108,866
| +8% | +$11.6M | 2.48% | 10 |
|
|
2025
Q1 | $129M | Buy |
1,300,910
+156,979
| +14% | +$15.6M | 2.58% | 8 |
|
|
2024
Q4 | $103M | Buy |
1,143,931
+191,887
| +20% | +$17.2M | 2.1% | 8 |
|
|
2024
Q3 | $64.1M | Buy |
952,044
+88,081
| +10% | +$5.93M | 1.66% | 14 |
|
|
2024
Q2 | $66.5M | Buy |
863,963
+107,729
| +14% | +$8.3M | 0.9% | 26 |
|
|
2024
Q1 | $60.2M | Buy |
756,234
+305,356
| +68% | +$24.3M | 1.1% | 24 |
|
|
2023
Q4 | $26.1M | Buy |
+450,878
| New | +$26.1M | 0.68% | 35 |
|